 Meda's pharmaceuticals are sold in more than 150 countries.Meda was listed on the Stockholm stock market until it was acquired by Mylan in 2016 through a cash and stock offer.In 2014, Meda acquired the Italian firm RottaPharm Madaus in order to add consumer health products to their portfolio.